Neostigmine Methylsulfate

Specifications

51-60-5CAS Number

200-109-5EC Number

[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;methyl sulfateIUPAC Name

C13H22N2O6SChemical Formula

334.39 g/molMolecular Weight

Neostigmine methyl sulfate; 51-60-5; NEOSTIGMINE METHYLSULFATE; Neostigmine metilsulfate; Syntostigmin; Neostigmine methylsulphate; Proserine; Intrastigmina; Bloxiverz; (m-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamate; NSC-93753; Neostigmini metilsulfas; 98IMH7M386; Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, methyl sulfate; CHEBI:7516; DTXSID40199003; PREVDUO COMPONENT NEOSTIGMINE METHYLSULFATE; Robinul-neostig; Stiglyn 1:500; RefChem:55702; Methylsulfate, Neostigmine; NEOSTIGMINE METHYSULFATE; DTXCID30121494; 3-(Dimethylcarbamoyloxy)-N,N,N-trimethylanilinium methyl sulfate; 200-109-5; Hodostin; Neostigmeth; Polstigmine; Synstigmine; Neostigmine (methyl sulfate); 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium methyl sulfate; 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium methyl sulfate; Neostigmine methosulfate; Neostigmine monomethyl sulfate; Eustigmin methyl sulfate; Proserine methyl sulfate; Stigmanol methyl sulfate; Stigmosan methyl sulfate; Neoeserine methyl sulfate; Syntostigmin (injection); Leostigmine methyl sulfate; Kirkstigmine methyl sulfate; Philostigmin methyl sulfate; Syntostigmin methyl sulfate; Vagostigmine methyl sulfate; Syntostigmine methyl sulfate; Synthostigmine methyl sulfate; AR-32; SB-23; TL-1394; MFCD00011796; MLS000028383; CHEMBL211471; [3-(Dimethylcarbamoxy)phenyl]trimethylammonium methyl sulfate; [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;methyl sulfate; (3-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamic ester; (3-(Dimethylcarbamoxy)phenyl)trimethylammonium methyl sulfate; SMR000058592; Prostigmin (TN); (3-(Dimethylcarbamoyl)oxyphenyl)trimethylammonium methyl sulfate; 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium methyl sulfate; Syntostigmin (VAN); Eustigmin methylsulfate; Proserinum; Neostigmine monomethylsulfate; Neostigminmetilsulfat; CCRIS 3274; GD 65; EINECS 200-109-5; NSC 93753; Neostigmine methyl sulphate; Kirkstigmine; Proserin; [3-(Dimethylcarbamoyl)oxyphenyl]trimethylammonium methyl sulfate; 51-60-5 (methylsulfate); UNII-98IMH7M386; Synstigmine;; Proserin;; Neostigmine metilsulfate; 3-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium methyl sulfate; Bloxiverz (TN); Neostigmine methylsulfate [USP:JAN]; Neostigminemethylsulfate; Neosigmine Methylsulfate; 3-(Dimethylcarbamoxy)phenyl trimethylammonium methyl sulfate; Opera_ID_536; Prostigmin methyl sulfate; Ammonium, (3-(dimethylcarbamoyloxy)phenyl)trimethyl-, methylsulfate; Dimethylcarbamic ester of 3-oxyphenyltrimethylammonium methylsulfate; Prostigmine methyl sulfate; Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate; Carbamic acid, N,N-dimethyl-, 3-dimethylaminophenyl ester, methosulfate; Neostigmine metilsulfate RS; Carbamic acid, N,N-dimethyl-, 3-(trimethylammonio)phenyl ester, methylsulfate; Neostigmine metilsulfate CRS; Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium methyl sulfate; SCHEMBL41903; MLS001148660; MLS001333720; orb1224846; orb1308019; HMS500J20; HY-B1206R; OSZNNLWOYWAHSS-UHFFFAOYSA-M; HMS2234E04; HMS3371E13; HY-B1206; NSC93753; EBC-08150; AKOS015856682; Neostigmine methylsulfate (JP18/USP); AC-6847; CCG-213722; CS-4698; FN40361; NEOSTIGMINE METHYL SULFATE [MI]; NEOSTIGMINE METHYLSULFATE [JAN]; NEOSTIGMINE METILSULFATE [MART.]; Neostigmine (methyl sulfate) (Standard); NEOSTIGMINE METHYLSULFATE [VANDF]; NEOSTIGMINE METILSULFATE [WHO-DD]; NEOSTIGMINE METILSULFATE [WHO-IP]; AS-15291; NEOSTIGMINE METHYLSULFATE [USP-RS]; Ammonium, methyl sulfate, dimethylcarbamate; DB-051998; Benzenaminium,N,N-trimethyl-, methyl sulfate; N0447; NS00076290; ST51006794; NEOSTIGMINE METHYLSULFATE [GREEN BOOK]; NEOSTIGMINI METILSULFAS [WHO-IP LATIN]; C08200; C75419; D00998; NEOSTIGMINE METHYLSULFATE [ORANGE BOOK]; NEOSTIGMINE METHYLSULFATE [USP IMPURITY]; NEOSTIGMINE METILSULFATE [EP MONOGRAPH]; WLN: 1N1&VOR CK1&1&1 &Q &OSW1; EN300-6731072; NEOSTIGMINE METHYLSULFATE [USP MONOGRAPH]; F160200; Q27107519; Z2037281404; (3-Dimethylcarbamoyloxyphenyl)trimethylammonium Methyl Sulfate; (3-Hydroxyphenyl)trimethylammonium Methyl Sulfate Dimethylcarbamate; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium;methyl sulfate; 3-(dimethylcarbamoyloxy)-N,N,N-trimethylbenzenaminium methyl sulfate; Dimethylcarbamic ester of 3-oxyphenyltrimethylammonium methylsulfato; (M-HYDROXYPHENYL)TRIMETHYLAMMONIUM METHYL SULPHATE DIMETHYLCARBAMATE; 3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium methyl sulfate; Carbamic acid, ester with (m-hydroxyphenyl)trimethylammonium methyl sulfate; Carbamic acid,N-dimethyl-, 3-(trimethylammonio)phenyl ester, methyl sulfate; N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, methyl hydroxysulfonate; Neostigmine methyl sulfate, European Pharmacopoeia (EP) Reference Standard; BENZENAMINIUM, 3-(((DIMETHYLAMINO)CARBONYL)OXY)-N,N,N-TRIMETHYL-, METHYL SULPHATE; Neostigmine methyl sulfate, United States Pharmacopeia (USP) Reference StandardSynonyms